Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Cabinet Becker Et Associes patent opposition analysis

Law FirmOpposition Filing Analysis

The comprehensive analysis of Cabinet Becker Et Associes opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cabinet Becker Et Associes

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3485890	Treatment Of Metabolic Disorders In Canine Animals	BOEHRINGER INGELHEIM VETMEDICA	Feb 9, 2024	CEVA SANTE ANIMALE
EP3035958	Porcine Circovirus Type 2 (Pcv2) Subunit Vaccine	BOEHRINGER INGELHEIM VETMEDICA	Jul 26, 2023	CEVA SANTE ANIMALE
EP3440243	Biodegradable Polyamide Fiber, Process For Obtaining Such Fiber And Polyamide Article Made Therefrom	RHODIA POLIAMIDA E ESPECIALIDADES	Mar 21, 2023	NILIT
EP3291679	Altering Microbial Populations & Modifying Microbiota	SNIPR	Sep 14, 2022	ELIGO BIOSCIENCE
EP3473101	Isoxazoline Compositions And Their Use As Antiparasitics For Felines	INTERVET	Feb 11, 2022	CEVA SANTE ANIMALE
EP2836223	Probiotic Bacteria	SKINBIOTHERAPEUTICS	Jan 28, 2022	CABINET BECKER ET ASSOCIES
EP2275132	Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them	BOEHRINGER INGELHEIM VETMEDICA	Dec 2, 2021	CEVA SANTE ANIMALE
EP3351267	Vaccine For Protection Against Lawsonia Intracellularis	INTERVET	May 4, 2021	CEVA SANTE ANIMALE
EP3206716	Use Of Cannabinoids In The Treatment Of Epilepsy	GW PHARMA	Apr 29, 2021	JAMES POOLE
EP3127551	Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Apr 27, 2021	CEVA SANTE ANIMALE

Top companies who are the clients of Cabinet Becker Et Associes